Our rare disease research experts have the experience and expertise to guide your clinical trials.
Vice President, Rare Disease & Pediatrics
Angi Robinson has been studying rare diseases at Premier Research for 14 years. She has provided oversight and management support for more than 30 rare disease studies in the U.S. and globally and has supported FDA pre-IND meetings, IND submissions, and NDA/BLA project directorship. Robinson has worked on industry sponsored studies to support the approvals of four drugs with orphan drug designations.
Ms. Robinson helped launch the first Best Pharmaceuticals for Children Act coordinating center, collaborating with leaders at the National Institute of Child Health and Human Development. She served as Project Manager for highly complex trials, including sedation in pediatric intensive care units and pediatric bipolar disorder. Her experience includes multiple study designs including PK/PD, adaptive design, and FDA fast track and breakthrough therapy designations.
Ms. Robinson began her career in laboratory quality control and has worked in clinical trial management as a Project Director/Manager, Clinical Lead, and Clinical Monitor. She holds a bachelor’s degree in cell and molecular biology from Tulane University.
Executive Director, Patient Engagement & Strategic Development
Juliet Moritz has worked in clinical research for more than 25 years, and her extensive background covers the spectrum from single-site studies to large, multinational trials. She joined Premier Research in 2016 to specialize in rare diseases, supporting the strategic development of products that address unmet medical needs associated with rare and orphan afflictions.
Prior to joining Premier Research, Ms. Moritz was Associate Director of Global Project Management at PPD Inc., overseeing infectious and respiratory disease research, and prior to that was Associate Director of Clinical Research at Knopp Biosciences. She held senior positions at small, mid-size, and large pharma companies as well as CROs, and began her career as a clinical research associate. She recently created and stepped into the position of Executive Director, Patient Engagement at Premier Research, a role which allows her to marry her deep clinical development experience with her passion for patient centric research. Ms. Moritz will be responsible for development of patient-centric processes throughout Premier’s services offerings.
Ms. Moritz holds a Master of Public Health degree from the Drexel University School of Public Health and a bachelor’s degree in biology from the University of Pennsylvania. She is currently pursuing her doctorate in bioethics through Albany Medical College and is in the process of completing the Stanford Professional Certificate in genetics and genomics.